Showing results (2041-2050 of 2,394) with videos related to
Sort By:
Pageof 240
The AAPS Journal|January 5, 2020
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging AgentHerman Gill, Richard Seipert, Vincent M Carroll, et al.The AAPS Journal|January 5, 2020
Estimation of the Effect of OAT2-Mediated Active Uptake on Meloxicam Exposure in the Human LiverRui Li, Sumathy Mathialagan, Jonathan J Novak, et al.The AAPS Journal|August 31, 2020
Inter-compound and Intra-compound Global Sensitivity Analysis of a Physiological Model for Pulmonary Absorption of Inhaled CompoundsNicola Melillo, Silvia Grandoni, Nicola Cesari, et al.The AAPS Journal|April 6, 2006
Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experimentsAndrew Hooker, Paolo ViciniThe AAPS Journal|April 6, 2006
Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systemsNicholas Bodor, Peter BuchwaldThe AAPS Journal|April 6, 2006
Viewing chemokines as a third major system of communication in the brainMartin W Adler, Ellen B Geller, Xiaohong Chen, et al.The AAPS Journal|April 6, 2006
N-n-alkylnicotinium analogs, a novel class of antagonists at alpha 4 beta 2* nicotinic acetylcholine receptors: inhibition of S(-)-nicotine-evoked 86Rb+ efflux from rat thalamic synaptosomesLincoln H Wilkins, Dennis K Miller, Joshua T Ayers, et al.The AAPS Journal|April 7, 2006
Commentary: where and how could biomarkers be used in 2016?M J Finley Austin, Lee BabissThe AAPS Journal|April 6, 2006
Role of bioactivation in drug-induced hypersensitivity reactionsJoseph P Sanderson, Dean J Naisbitt, B Kevin ParkThe AAPS Journal|April 6, 2006
CNS drug delivery: opioid peptides and the blood-brain barrierKen A Witt, Thomas P DavisPageof 240